Clinical Trial Update: Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for cosibelimab in cutaneous squamous cell carcinoma in patients with kidney transplant or hematologic malignancy; the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Squamous Cell Carcinoma

Drugs mentioned

• cosibelimab (cosibelimab)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Cutaneous Squamous Cell Carcinoma, Skin Cancer | Phase 4 | Status: NOT_YET_RECRUITING